Epstein-Barr virus subtype distribution in angioimmunoblastic lymphadenopathy

Area of Science:

• Oncology
• Virology
• Immunology

Background:

• Angioimmunoblastic lymphadenopathy-type T-cell lymphoma (AILD-TCL) is an aggressive non-Hodgkin lymphoma.
• Epstein-Barr virus (EBV) is a common human herpesvirus implicated in various lymphoid malignancies.
• The distribution of EBV subtypes in AILD-TCL is not well-characterized.

Purpose of the Study:

• To investigate the presence and distribution of Epstein-Barr virus (EBV) subtypes 1 and 2 in patients with AILD-TCL.
• To correlate EBV subtype findings with established methods for EBV detection.

Main Methods:

• Tissue samples from 16 AILD-TCL patients were analyzed.
• Epstein-Barr virus (EBV) association was confirmed using polymerase chain reaction (PCR) for EBV-DNA, in situ hybridization (ISH) for EBV-encoded small nuclear RNAs (EBER), and immunohistology for EBV-encoded latent membrane protein (LMP).
• EBV subtypes were determined in 12 cases.

Main Results:

• EBV-DNA, EBER, and LMP were detected in AILD-TCL tissues, confirming EBV association.
• PCR and EBER-ISH showed largely concordant results, with some discrepancies.
• Among 12 typed cases, 1 contained EBV subtype 2, 3 contained subtype 1, and 4 contained both subtypes. Four cases remained untyped.

Conclusions:

• Epstein-Barr virus (EBV) subtype 2 can be found in angioimmunoblastic lymphadenopathy-type T-cell lymphoma (AILD-TCL).
• The presence of EBV subtype 2 in AILD-TCL may be associated with progressive immunodysfunction.
• These findings contribute to understanding the role of EBV in lymphomagenesis, particularly in immunocompromised states.